National
News
Features
Profiles/Interviews
Local Sports
Global
Football
Middle East
Basketball
Africa
Europe
Americas
Asia
Baseball
Cricket
Australasia
Racing
Rugby
Olympics
Yalla Jordan
The Royal wedding
Where to Go
Around Jordan
Cartoon
Business
Economy
Trade & Industry
Entrepreneurship
Opinion & Analysis
Analysis
Opinion
Lifestyle
Good Food
Health
Fashion
Culture & Arts
Travel
Entertainment
Education
Music
Technology
Gaming
Drive
Reviews
Books
Trending
Odd & Bizarre
Property
Weather
Home
National
News
Features
Profiles/Interviews
Local Sports
Global
REGION & WORLD
Middle East
Africa
Europe
Americas
Asia
Australasia
SPORTS
Football
Basketball
Baseball
Cricket
Racing
Rugby
Olympics
Yalla Jordan
The Royal wedding
Where to Go
Around Jordan
Cartoon
Business
Economy
Trade & Industry
Entrepreneurship
Opinion & Analysis
Analysis
Opinion
Lifestyle
Good Food
Health
Fashion
Culture & Arts
Travel
Entertainment
Education
Music
Technology
Gaming
Drive
Reviews
Books
Trending
Odd & Bizarre
Property
Weather
Breaking News:
Pezeshkian: We Will Not Back Down in the Face of Any Threats
Gaza Martyr Toll Since October 7 Approaches 73,000
The Great Arab Revolt, Army Day, and the Throne Day: A Narrative of a Homeland Written with Resolve and Pride
Hamas: The Occupation Respects No Covenant and Adheres to No Understanding
Cairo Hosts Talks to Reinforce the Gaza Truce
Iran Ends Operations Against Israel, Warns of Escalation in Lebanon
Israeli Military: We Targeted the Iranian Regime's Air Defenses
Trump: Israel and Iran are looking to reach an immediate ceasefire
Israel Suspends Humanitarian Aid to Gaza Until Further Notice
4 Martyrs in Israeli Airstrikes on Southern Lebanon
June 8 2026
8:15 PM
Newsletter
Subscribe
Sign in
My Account
Sign out
#Hikma
Hikma and Celltrion strengthen partnership to expand biosimilar access in MENA
Oct 07,2025
|
Trade & Industry
S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable
May 11,2025
|
Trade & Industry
Hikma, Celltrion sign monoclonal antibody licensing agreement
Nov 29,2022
|
All
Hikma’s success story: how to revive industry
Oct 15,2022
|
Opinion
HM stresses importance of pharmaceutical sector to economy at Hikma inaugration
Sep 06,2022
|
News
Hikma, Adalvo agree to commercialize allergic Rhinitis
Aug 31,2022
|
All
Hikma, MPP sign licensing agreement for COVID-19 pill
Jan 21,2022
|
All
Hikma to acquire Custopharm for $375 million
Sep 27,2021
|
News
Hikma announces good 2021 start, reiterates full year guidance
May 01,2021
|
All